{"id":50820,"date":"2022-11-14T17:02:07","date_gmt":"2022-11-14T16:02:07","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/"},"modified":"2022-11-14T17:02:07","modified_gmt":"2022-11-14T16:02:07","slug":"flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/","title":{"rendered":"Flow Cytometry Market &#8211; Global Forecast to 2027: Opportunities in the Adoption of Recombinant DNA Technology for Antibody Production &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4912109\/global-flow-cytometry-market-by-technology-cell?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=chbpsw&amp;utm_campaign=1775650+-+Flow+Cytometry+Market+-+Global+Forecast+to+2027%3A+Opportunities+in+the+Adoption+of+Recombinant+DNA+Technology+for+Antibody+Production&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Flow Cytometry Market by Technology (Cell-based, Bead-based), Product &amp; Service (Analyzer, Sorter, Consumables, Software), Application ((Research &#8211; Immunology, Stem cell), (Clinical &#8211; Hematology)), End user (Biotech, Hospitals) &#8211; Forecast to 2027&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221114005771\/en\/1636063\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221114005771\/en\/1636063\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global flow cytometry market is projected to reach USD 6.9 billion by 2027 from USD 4.7 billion in 2022, at a CAGR of 8.1%\n<\/p>\n<p>\nThe rising prevalence of HIV\/AIDS, cancer &amp; autoimmune diseases across the globe is increasing the adoption of flow cytometry for diagnosis hence projecting market growth. Additionally, the launch of technologically advent products is furthermore likely to propel the market growth during the forecast period of 2022-2027.\n<\/p>\n<p>\n<strong><em>Instruments segment held a substantial share in the global flow cytometry market in 2021.<\/em><\/strong>\n<\/p>\n<p>\nBased on products &amp; services, the market is segmented into reagents &amp; consumables, instruments, services, software and accessories. The reagents &amp; consumables segment held a dominant share in the market in 2021 and is anticipated to continue dominance during the forecast period.\n<\/p>\n<p>\nThe launch of new reagents &amp; consumables in the market which are making research grow at a faster pace is likely to drive segmental growth. In November 2021, Bio-Rad Laboratories, Inc. (US), launched StarBright UltraViolet 400 Dye, fluorescent nanoparticles designed for use with a UV laser in flow cytometry applications.\n<\/p>\n<p>\n<strong><em>Research applications segment dominated the market in 2021.<\/em><\/strong>\n<\/p>\n<p>\nBased on end user, the flow cytometry market is segmented into research applications, clinical applications, and industrial applications.\n<\/p>\n<p>\nThe strong focus of key market players in the clinical applications of flow cytometry is likely to project segmental growth. For instance, in October 2021, BD (Becton, Dickinson and Company)(US), in collaboration with Christian Medical College Vellore (India) launched its second Center of Excellence (CoE) in flow cytometry for clinical research in India.\n<\/p>\n<p>\n<strong><em>North America held a dominant share in 2021.<\/em><\/strong>\n<\/p>\n<p>\nGeographically, the flow cytometry market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2021, North America accounted for the major share of the flow cytometry market. North America held a dominant share owing to the presence of key market players coupled with increased adoption of flow cytometry in research applications in the region.\n<\/p>\n<p>\nThe Asia Pacific is expected to grow at a faster pace due to increased research funding and adoption of flow cytometry in clinical applications.\n<\/p>\n<p>\n<strong><em>Competitive landscape<\/em><\/strong>\n<\/p>\n<p>\nThe prominent players in the flow cytometry market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), and Luminex Corporation (US).\n<\/p>\n<p>\n<strong>Premium Insights<\/strong>\n<\/p>\n<ul>\n<li>\nIncreasing Prevalence of Autoimmune Diseases and Rising Advancements in Flow Cytometry Techniques Drive Market Growth\n<\/li>\n<li>\nReagents &amp; Consumables Segment Accounted for Largest Share in 2021\n<\/li>\n<li>\nCell-based Flow Cytometry Segment to Dominate Market During Forecast Period\n<\/li>\n<li>\nChina to Register Highest Growth During Forecast Period\n<\/li>\n<\/ul>\n<p>\n<strong>Market Dynamics<\/strong>\n<\/p>\n<p>\nDrivers\n<\/p>\n<ul>\n<li>\nIncreasing Incidence of HIV\/Aids and Cancer\n<\/li>\n<li>\nFlow Cytometry Techniques in Research Activities\n<\/li>\n<li>\nUse of Flow Cytometry in Regenerative Medicine\n<\/li>\n<li>\nGrowing Public-Private Initiatives in Immunology and Immuno-Oncology Research\n<\/li>\n<li>\nTechnological Advancements in Flow Cytometry Instruments\n<\/li>\n<\/ul>\n<p>\nRestraints\n<\/p>\n<ul>\n<li>\nHigh Product Cost\n<\/li>\n<\/ul>\n<p>\nOpportunities\n<\/p>\n<ul>\n<li>\nEmerging Markets\n<\/li>\n<li>\nPublic-Private Funding Initiatives in Stem Cell Research\n<\/li>\n<li>\nAdoption of Recombinant DNA Technology for Antibody Production\n<\/li>\n<\/ul>\n<p>\nChallenges\n<\/p>\n<ul>\n<li>\nComplexities Related to Reagent Development\n<\/li>\n<li>\nShortage of Well-Trained and Skilled Professionals\n<\/li>\n<\/ul>\n<p>\nPatent Analysis\n<\/p>\n<p>\nValue Chain Analysis\n<\/p>\n<ul>\n<li>\nEcosystem Analysis\n<\/li>\n<li>\nRole in Ecosystem\n<\/li>\n<\/ul>\n<p>\nRegulatory Assessment\n<\/p>\n<ul>\n<li>\nStringent FDA Requirements\n<\/li>\n<li>\nAnalyte-Specific Reagent Rule\n<\/li>\n<li>\nLimitations in Validation Protocols for Cell-based Assays\n<\/li>\n<li>\nAbsence of Test Guidelines on Cell-based Fluorescence Assays\n<\/li>\n<li>\nIVD Ce Mark Approvals\n<\/li>\n<\/ul>\n<p>\nUS: Reimbursement Scenario\n<\/p>\n<p>\n<strong>Company Profiles<\/strong>\n<\/p>\n<p>\nKey Players\n<\/p>\n<ul>\n<li>\nBD\n<\/li>\n<li>\nDanaher Corporation\n<\/li>\n<li>\nThermo Fisher Scientific, Inc.\n<\/li>\n<li>\nAgilent Technologies, Inc.\n<\/li>\n<li>\nSony Biotechnology Inc. (A Subsidiary of Sony Group Corporation)\n<\/li>\n<li>\nBio-Rad Laboratories Inc.\n<\/li>\n<li>\nMiltenyi Biotec\n<\/li>\n<li>\nEnzo Biochem, Inc.\n<\/li>\n<li>\nSysmex Corporation\n<\/li>\n<li>\nLuminex Corporation (A Diasorin Company)\n<\/li>\n<li>\nBiomerieux SA\n<\/li>\n<li>\nCytonome\/St, LLC.\n<\/li>\n<li>\nSartorius AG\n<\/li>\n<li>\nCytek Biosciences\n<\/li>\n<li>\nUnion Biometrica, Inc.\n<\/li>\n<\/ul>\n<p>\nOther Players\n<\/p>\n<ul>\n<li>\nApogee Flow Systems Ltd.\n<\/li>\n<li>\nStratedigm, Inc.\n<\/li>\n<li>\nNanocellect Biomedical, Inc.\n<\/li>\n<li>\nOn-Chip Biotechnologies Co. Ltd.\n<\/li>\n<li>\nNexcelom Bioscience LLC.\n<\/li>\n<li>\nBennubio Inc.\n<\/li>\n<li>\nOrflo Technologies\n<\/li>\n<li>\nBay Bioscience Co. Ltd.\n<\/li>\n<li>\nCytobuoy B.V.\n<\/li>\n<li>\nBiolegend, Inc.\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4912109\/global-flow-cytometry-market-by-technology-cell?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=chbpsw&amp;utm_campaign=1775650+-+Flow+Cytometry+Market+-+Global+Forecast+to+2027%3A+Opportunities+in+the+Adoption+of+Recombinant+DNA+Technology+for+Antibody+Production&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/6luffi<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;t&#x6f;&#58;&#x70;&#x72;e&#x73;&#115;&#64;&#x72;&#101;&#x73;&#101;a&#x72;&#99;h&#x61;&#110;&#x64;&#109;a&#x72;&#107;&#x65;&#x74;s&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#101;s&#x73;&#x40;&#114;es&#x65;&#x61;&#114;c&#x68;&#x61;&#110;&#100;m&#x61;&#x72;&#107;e&#x74;&#x73;&#46;&#99;o&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Flow Cytometry Market by Technology (Cell-based, Bead-based), Product &amp; Service (Analyzer, Sorter, Consumables, Software), Application ((Research &#8211; Immunology, Stem cell), (Clinical &#8211; Hematology)), End user (Biotech, Hospitals) &#8211; Forecast to 2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global flow cytometry market is projected to reach USD 6.9 billion by 2027 &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50820","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Flow Cytometry Market - Global Forecast to 2027: Opportunities in the Adoption of Recombinant DNA Technology for Antibody Production - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Flow Cytometry Market - Global Forecast to 2027: Opportunities in the Adoption of Recombinant DNA Technology for Antibody Production - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Flow Cytometry Market by Technology (Cell-based, Bead-based), Product &amp; Service (Analyzer, Sorter, Consumables, Software), Application ((Research &#8211; Immunology, Stem cell), (Clinical &#8211; Hematology)), End user (Biotech, Hospitals) &#8211; Forecast to 2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global flow cytometry market is projected to reach USD 6.9 billion by 2027 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-14T16:02:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221114005771\/en\/1636063\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Flow Cytometry Market &#8211; Global Forecast to 2027: Opportunities in the Adoption of Recombinant DNA Technology for Antibody Production &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-11-14T16:02:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\\\/\"},\"wordCount\":724,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221114005771\\\/en\\\/1636063\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\\\/\",\"name\":\"Flow Cytometry Market - Global Forecast to 2027: Opportunities in the Adoption of Recombinant DNA Technology for Antibody Production - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221114005771\\\/en\\\/1636063\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-11-14T16:02:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221114005771\\\/en\\\/1636063\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221114005771\\\/en\\\/1636063\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Flow Cytometry Market &#8211; Global Forecast to 2027: Opportunities in the Adoption of Recombinant DNA Technology for Antibody Production &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Flow Cytometry Market - Global Forecast to 2027: Opportunities in the Adoption of Recombinant DNA Technology for Antibody Production - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Flow Cytometry Market - Global Forecast to 2027: Opportunities in the Adoption of Recombinant DNA Technology for Antibody Production - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Flow Cytometry Market by Technology (Cell-based, Bead-based), Product &amp; Service (Analyzer, Sorter, Consumables, Software), Application ((Research &#8211; Immunology, Stem cell), (Clinical &#8211; Hematology)), End user (Biotech, Hospitals) &#8211; Forecast to 2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global flow cytometry market is projected to reach USD 6.9 billion by 2027 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-14T16:02:07+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221114005771\/en\/1636063\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Flow Cytometry Market &#8211; Global Forecast to 2027: Opportunities in the Adoption of Recombinant DNA Technology for Antibody Production &#8211; ResearchAndMarkets.com","datePublished":"2022-11-14T16:02:07+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/"},"wordCount":724,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221114005771\/en\/1636063\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/","name":"Flow Cytometry Market - Global Forecast to 2027: Opportunities in the Adoption of Recombinant DNA Technology for Antibody Production - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221114005771\/en\/1636063\/21\/logo.jpg","datePublished":"2022-11-14T16:02:07+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221114005771\/en\/1636063\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221114005771\/en\/1636063\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/flow-cytometry-market-global-forecast-to-2027-opportunities-in-the-adoption-of-recombinant-dna-technology-for-antibody-production-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Flow Cytometry Market &#8211; Global Forecast to 2027: Opportunities in the Adoption of Recombinant DNA Technology for Antibody Production &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50820","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50820"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50820\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50820"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50820"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50820"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}